Reference
Kim HL, et al. Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B. Gut : 25 Nov 2020. Available from: URL: http://doi.org/10.1136/gutjnl-2020-321309
Rights and permissions
About this article
Cite this article
Early antiviral treatment in chronic hepatitis B saves lives and costs. PharmacoEcon Outcomes News 868, 12 (2020). https://doi.org/10.1007/s40274-020-7344-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7344-x